Overview

Absorption of Antibiotics With High Oral Bioavailability in Short-bowel Syndrome

Status:
Not yet recruiting
Trial end date:
2024-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the drug absorption of oral antibiotics in patients with short bowel syndrome.
Phase:
Phase 1
Details
Lead Sponsor:
Central Hospital, Nancy, France
Collaborators:
FIlière des Maladies rares Abdomino-THOraciques
Fresenius Kabi
Société Francophone Nutrition Clinique et Métabolisme
Treatments:
Amoxicillin
Levofloxacin
Ofloxacin
Sulfamethoxazole
Trimethoprim
Trimethoprim, Sulfamethoxazole Drug Combination